COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?

被引：8
|
作者：
Marmor, Michael F. [1 ,2 ]
机构：
[1] Stanford Univ, Dept Ophthalmol, Sch Med, Palo Alto, CA 94305 USA
[2] Stanford Univ, Byers Eye Inst, Sch Med, Palo Alto, CA 94305 USA
来源：
AMERICAN JOURNAL OF OPHTHALMOLOGY | 2020年 / 216卷
关键词：
HYDROXYCHLOROQUINE; TRIAL; RETINOPATHY; CHLOROQUINE; INHIBITION; AUTOPHAGY;
D O I：
10.1016/j.ajo.2020.03.029
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：A1 / A2
页数：2
相关论文
共 50 条
  • [41] Liquid Chromatographic Methods for COVID-19 Drugs, Hydroxychloroquine and Chloroquine
    Bilgin, Zeynep Derya
    Evcil, Isil
    Yazgi, Didem
    Binay, Gokce
    Genc, Ceren Okuyucu
    Gulsen, Busra
    Huseynova, Aytaj
    Ozdemir, Ayse Zehra
    Ozmen, Emel
    Usta, Yakup
    Ustun, Suade
    Andac, Sena Caglar
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2021, 59 (08) : 748 - 757
  • [42] The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19
    Manivannan, Elangovan
    Karthikeyan, Chandrabose
    Moorthy, N. S. Hari Narayana
    Chaturvedi, Subash Chandra
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [43] Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19
    Ruamviboonsuk, Paisan
    Lai, Timothy Y. Y.
    Chang, Andrew
    Lai, Chi-Chun
    Mieler, William F.
    Lam, Dennis S. C.
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2020, 9 (02): : 85 - 87
  • [44] Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals
    Mallhi, Tauqeer Hussain
    Ahmad, Abrar
    Butt, Muhammad Hammad
    Misbah, Shahzadi
    Khan, Yusra Habib
    Alotaibi, Nasser Hadal
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2020, 30 (10): : S124 - S128
  • [45] Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19
    Lei, Zi-Ning
    Wu, Zhuo-Xun
    Dong, Shaowei
    Yang, Dong-Hua
    Zhang, Litu
    Ke, Zunfu
    Zou, Chang
    Chen, Zhe-Sheng
    PHARMACOLOGY & THERAPEUTICS, 2020, 216
  • [46] Emergency Approval of Chloroquine and Hydroxychloroquine for Treatment of COVID-19 (updated to Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19) (vol 54, pg 613, 2020)
    Piszczatoski, C. R.
    Powell, J.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (08) : 832 - 832
  • [47] Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID-19 Infection
    Nicol, Melanie R.
    Joshi, Abhay
    Rizk, Matthew L.
    Sabato, Philip E.
    Savic, Radojka M.
    Wesche, David
    Zheng, Jenny H.
    Cook, Jack
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (06) : 1135 - 1149
  • [48] Clinical Efficacy of Hydroxychloroquine or Chloroquine in Patients with COVID-19: An Umbrella Review
    Shahsavarinia, Kavous
    Ghojazadeh, Morteza
    Sanaie, Sarvin
    Vahedi, Leila
    Ahmadpour, Mahta
    Mahmoodpoor, Ata
    Soleimanpour, Hassan
    PHARMACEUTICAL SCIENCES, 2021, 27 (04) : 481 - 488
  • [49] Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations
    Biswas, Partha Sarathi
    Sen, Devosri
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2020, 11
  • [50] Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence
    Roustit, M.
    Guilhaumou, R.
    Molimard, M.
    Drici, M-D
    Laporte, S.
    Montastruc, J-L
    THERAPIE, 2020, 75 (04): : 363 - 370
12345